The influence of hyaluronic acid on vascular endothelial cell proliferation and the relationship with ezrin/merlin expression.
It has been established that hyaluronic acid (HA) glycans (nHA) and oligosaccharide (oHA) exert different effects on the biological function of the vascular endothelial cell (EC), resulting in altered regulation of angiogenesis. However, the specific mechanism is still unclear. Our study focused on the effects of nHA and oHA on the ezrin and merlin proteins in EC. The expression of ezrin and merlin was silenced by siRNA, and the regulation on EC growth as well as the mRNA expression and activation (phosphorylation) of ezrin and merlin stimulated by oHA and nHA was investigated. The results revealed that when treated with nHA, there was no significant change in ezrin expression or activation. After being treated with oHA, the expression and activation of ezrin were definitively increased whereas there were no obvious changes in merlin expression (including its phosphorylation). With ezrin expression silenced, the expression of merlin as well as its phosphorylation levels in nHA-stimulated human umbilical vein endothelial cells were notably elevated, while there was no significant change induced by oHA. With merlin expression silenced, no obvious change was found in the expression of ezrin (including its phosphorylation) induced by nHA. Conversely, the expression of ezrin and its activation was significantly improved after being treated with oHA. The results suggest that the mechanism for the promotion of EC proliferation by oHA is likely related to the expression and activation of ezrin, and the inhibition of EC proliferation by nHA is likely related to the expression and activation of merlin.
Department of Pathogen Biology and Immunology, Guangzhou Medical University, China.
Wei
W
Mo
Cuixia
C
Yang
Yiwen
Y
Liu
Yiqing
Y
He
Yingzhi
Y
Wang
Feng
F
Gao
D049109:Cell Proliferation / Q000187:drug effects*; D002478:Cells, Cultured; D003598:Cytoskeletal Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology* / Q000378:metabolism*; D055785:Gene Knockdown Techniques; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D025581:Neurofibromin 2 / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D009844:Oligosaccharides / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D011134:Polysaccharides / Q000494:pharmacology; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000235:genetics; D000099149:Ezrin
D003598:Cytoskeletal Proteins; D006820:Hyaluronic Acid; D025581:Neurofibromin 2; D009844:Oligosaccharides; D011134:Polysaccharides; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D000099149:Ezrin